Table 3. The quality of evidence assessment of association between maternal folic acid supplementation and asthma/wheeze in childhood by the GRADE approach.
Outcomes | Exposure timing | Relative effect (95% CI) | No. of participants (studies) | Quality of evidence (GRADE) |
---|---|---|---|---|
Asthma in childhood | ||||
Pregnancy10,11,12 | RR=1.04 (0.94-1.16) | 7,925 (n=3) | ⊕⊕⊖⊖Low 1 | |
Pre-pregnancy9,10 | RR=0.98 (0.73-1.33) | 2,056 (n=2) | ⊕⊖⊖⊖Very Low 2 | |
Early pregnancy9,10,12 | RR=0.98 (0.78-1.23) | 4,696 (n=3) | ⊕⊕⊖⊖Low 3 | |
Other period in pregnancy11,12 | RR=1.03 (0.92-1.16) | 6,426 (n=2) | ⊕⊕⊖⊖Low 4 | |
Wheeze in childhood | ||||
Pregnancy11,12 | RR=1.05 (0.95-1.15) | 6,426 (n=2) | ⊕⊕⊖⊖Low 5 | |
Early pregnancy8,12,13 | RR=1.06 (1.02-1.09) | 43,459 (n=3) | ⊕⊕⊖⊖Low 6 | |
Other period in pregnancy8,11,12 | RR=1.01 (0.98-1.03) | 38,503 (n=3) | ⊕⊕⊖⊖Low 7 | |
Atopic Dermatitis | Early pregnancy12,13 | RR=1.15 (0.91-1.45) | 11,382 (n=2) | ⊕⊖⊖⊖Very Low 8 |
Eczema | Other period in pregnancy11,12 | RR=0.99 (0.89-1.10) | 6,426 (n=2) | ⊕⊕⊖⊖Low 9 |
Sensitization | Other period in pregnancy11,12 | RR=0.88 (0.75-1.03) | 6,426 (n=2) | ⊕⊕⊖⊖Low 10 |
1 No factors exist that can reduce or increase the quality of evidence.
2 (-1 imprecision) 95% CI overlaps no effect (CI includes RR of 1.0) and CI fails to exclude 0.75 and 1.25 though the sample size is very large.
3 No factors exist that can reduce or increase the quality of evidence.
4 No factors exist that can reduce or increase the quality of evidence.
5 No factors exist that can reduce or increase the quality of evidence.
6 No factors exist that can reduce or increase the quality of evidence.
7 No factors exist that can reduce or increase the quality of evidence.
8 (-1 imprecision) 95% CI overlaps no effect (CI includes RR of 1.0) and CI fails to exclude 1.25 though the sample size is very large.
9 No factors exist that can reduce or increase the quality of evidence.
10 No factors exist that can reduce or increase the quality of evidence.
RR, risk ratio; CI, confidence intervals.